These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27373141)

  • 1. Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™.
    Raes M; Strens D; Kleintjens J; Biundo E; Morel T; Vyse A
    Epidemiol Infect; 2016 Oct; 144(14):3017-3024. PubMed ID: 27373141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
    Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study.
    Forrest R; Jones L; Willocks L; Hardie A; Templeton K
    Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.
    Guerra SF; Linhares AC; Mascarenhas JD; Oliveira A; Justino MC; Soares LS; Müller EC; Brasil P; Tuboi S; Ortega-Barria E; Colindres R
    J Med Virol; 2015 Aug; 87(8):1303-10. PubMed ID: 25879653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.
    Restivo V; Caracci F; Sannasardo CE; Scarpitta F; Vella C; Ventura G; Tramuto F; Costantino C
    Acta Biomed; 2018 Oct; 89(3):437-442. PubMed ID: 30333453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Severity and Rotavirus Vaccination among Children Hospitalized for Acute Gastroenteritis in Belém, Northern Brazil.
    Justino MC; Brasil P; Abreu E; Miranda Y; Mascarenhas JD; Guerra SF; Linhares AC
    J Trop Pediatr; 2016 Aug; 62(4):276-81. PubMed ID: 26884442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.
    Mattei A; Sbarbati M; Fiasca F; Angelone AM; Mazzei MC; di Orio F
    Hum Vaccin Immunother; 2016; 12(2):534-9. PubMed ID: 26337458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK.
    Heinsbroek E; Hungerford D; Cooke RPD; Chowdhury M; Cargill JS; Bar-Zeev N; French N; Theodorou E; Standaert B; Cunliffe NA
    BMJ Open; 2019 May; 9(5):e027739. PubMed ID: 31097487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.
    Pendleton A; Galic M; Clarke C; Ng SP; Ledesma E; Ramakrishnan G; Liu Y
    Hum Vaccin Immunother; 2013 Aug; 9(8):1617-25. PubMed ID: 23733041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of rotavirus vaccines on rotavirus disease.
    Lepage P; Vergison A
    Expert Rev Anti Infect Ther; 2012 May; 10(5):547-61. PubMed ID: 22702319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
    Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
    Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
    Ledent E; Lieftucht A; Buyse H; Sugiyama K; Mckenna M; Holl K
    Drug Saf; 2016 Mar; 39(3):219-30. PubMed ID: 26748506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
    Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
    Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.